Vertex cystic fibrosis drug gets expanded approval for use in infants
August 15, 2018 at 16:39 PM EDT
U.S. health regulators have expanded the use of one of Vertex Pharmaceuticals Inc's cystic fibrosis drugs to include patients aged between 12 months and 24 months.